Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Coloplast A/S    COLO B   DK0060448595

COLOPLAST A/S

(COLO B)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 10/30 04:04:29 am
945.3 DKK   -0.24%
10:15aCOLOPLAST A/S : annual earnings release
09/30COLOPLAST A/S : completes minority investment in Francis Medical
AQ
09/29COLOPLAST A/S : completes minority investment in Francis Medical
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
10/23/2020 10/26/2020 10/27/2020 10/28/2020 10/29/2020 Date
973.8(c) 958.6(c) 967.4(c) 938(c) 947.6(c) Last
185 409 158 288 213 073 275 907 269 973 Volume
+0.50% -1.56% +0.92% -3.04% +1.02% Change
More quotes
Financials
Sales 2020 18 619 M 2 914 M 2 914 M
Net income 2020 4 262 M 667 M 667 M
Net Debt 2020 880 M 138 M 138 M
P/E ratio 2020 46,7x
Yield 2020 1,88%
Sales 2021 20 059 M 3 139 M 3 139 M
Net income 2021 4 864 M 761 M 761 M
Net Debt 2021 652 M 102 M 102 M
P/E ratio 2021 40,9x
Yield 2021 2,11%
Capitalization 199 B 31 508 M 31 221 M
EV / Sales 2020 10,8x
EV / Sales 2021 9,98x
Nbr of Employees 12 000
Free-Float 57,3%
More Financials
Company
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (49.1%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (39.9%): bags and equipment used following intestinal operations; - wound care and skincare products (13%): wound dressings, bandages, creams and... 
More about the company
Notations Surperformance© of Coloplast A/S
Trading Rating : Investor Rating :
More Ratings
All news about COLOPLAST A/S
10:15aCOLOPLAST A/S : annual earnings release
09/30COLOPLAST A/S : completes minority investment in Francis Medical
AQ
09/29COLOPLAST A/S : completes minority investment in Francis Medical
AQ
09/29Coloplast completes minority investment in Francis Medical
GL
09/29COLOPLAST A/S : - Announcement no. 09/2020 - Coloplast launches new 2025 strateg..
AQ
09/17COLOPLAST A/S : Florida Court Tosses Punitive Damages Outta Here!
AQ
08/28COLOPLAST A/S : - Announcement no. 08/2020 - Financial Calendar 2020-21
AQ
08/28COLOPLAST A/S : Provisional calendar
CO
08/25COLOPLAST A/S : - Transactions in connection with share buy-back programme, week..
AQ
08/24COLOPLAST A/S : - Transactions in connection with share buy-back programme, week..
AQ
08/19COLOPLAST A/S : Group - reports -2% organic Growth in Q3 due to significant nega..
AQ
08/18COLOPLAST A/S : reports -2% organic growth in Q3 due to significant negative imp..
AQ
08/18COLOPLAST A/S : - Announcement no. 07/2020 - Coloplast strengthens Executive Man..
AQ
08/18COLOPLAST A/S : - Announcement no. 06/2020 – 9M Interim Financial Report, ..
AQ
08/18COLOPLAST A/S : 3rd quarter results
CO
More news
News in other languages on COLOPLAST A/S
03:45aCOLOPLAST A/S : Veröffentlichung des Jahresergebnisses
03:45aCOLOPLAST A/S : publication des résultats annuels
10/16L'Europe se recroqueville
10/16AVIS D'ANALYSTES DU JOUR : CD Projekt, Eurofins, FDJ, Infineon, Just Eat, KVMH, ..
09/29COLOPLAST A/S : approche des sommets
More news
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 19
Average target price 949,44 DKK
Last Close Price 938,00 DKK
Spread / Highest target 25,8%
Spread / Average Target 1,22%
Spread / Lowest Target -19,5%
EPS Revisions
Managers
NameTitle
Kristian Villumsen President & Chief Executive Officer
Lars SÝren Rasmussen Chairman
Allan Rasmussen Executive Vice President-Global Operations
Anders Lonning-Skovgaard Chief Financial Officer & Executive Vice President
Oliver Johansen Senior VP-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
COLOPLAST A/S13.50%31 508
TOP GLOVE CORPORATION BHD.460.43%17 104
TELEFLEX INCORPORATED-11.00%15 584
HARTALEGA HOLDINGS228.83%14 804
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED63.60%8 916
SUPERMAX CORPORATION1,259.71%5 807